- Report
- June 2024
- 196 Pages
Global
From €4719EUR$4,950USD£4,022GBP
- Report
- March 2021
- 43 Pages
Global
€1257EUR$1,318USD£1,071GBP
- Book
- January 2014
- 624 Pages
€1717EUR$1,929USD£1,515GBP
- Book
- August 2024
North America
- Book
- July 2024
North America
- Book
- March 2023
North America
- Book
- November 2021
North America
Angioedema is a medical condition characterized by the swelling of the skin, mucous membranes, and subcutaneous tissues. It is a type of allergic reaction that is often associated with allergies and immunological disorders. Symptoms of angioedema include swelling of the face, lips, tongue, and throat, as well as hives, itching, and difficulty breathing. Treatment for angioedema typically involves the use of antihistamines, corticosteroids, and epinephrine. In severe cases, immunosuppressants may be prescribed.
The angioedema market is a rapidly growing segment of the allergy and immunology industry. It is driven by the increasing prevalence of allergies and immunological disorders, as well as the development of new treatments and therapies. Companies in the angioedema market include Allergan, Sanofi, GlaxoSmithKline, Novartis, and Pfizer. Show Less Read more